BioCryst公司的贝罗司他胶囊治疗什么病

What diseases does BioCryst treat?

Berostat capsule Orladeyo is a plasma kallikrein inhibitor that binds to plasma kallikrein and inhibits its proteolytic activity. Currently, Orladeyo, berosostat capsules, has been approved by the U.S. Food and Drug Administration (FDA) for the prevention of hereditary angioedema (HAE) attacks in children and adult patients aged ≥12 years. Berostat capsule Orladeyo is the first targeted oral therapy approved to prevent HAE attacks. The approval of Orladeyo will bring significant progress in the treatment of HAE patients with hereditary angioedema and will help reduce the treatment burden on patients.

Treatment with Orladeyo will also produce certain side effects or adverse reactions. The most common adverse reactions include: abdominal pain/vomiting/diarrhea/back pain/gastroesophageal reflux disease, etc. And patients should note: Berosostat capsules Orladeyo should not be used to treat acute attacks of hereditary angioedema (HAE). Before receiving treatment with Orladeyo, patients should go to the hospital for a detailed examination and strictly follow the doctor's diagnosis and treatment recommendations.

Berostat capsules Orladeyo are manufactured by BioCryst, a biotechnology company. BioCryst designs, optimizes and develops small molecule drugs that block enzymes involved in disease pathogenesis. The company focuses on treating rare diseases. BioCryst uses X-ray scattering technology, molecular structure computer simulations and chemical techniques to focus on the three-dimensional molecular structure and active site characteristics of enzymes that control cell biology.

The above is the introduction about Orladeyo. If patients have other questions about Orladeyo (such as drug prices, purchase channels, etc.), they can consult the medical companion travel service.

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.